Today's Information

Provided by: TaiMed Biologics Inc.
SEQ_NO 4 Date of announcement 2022/05/30 Time of announcement 15:49:23
Subject 
 Important Resolutions of the Company's 2022
General Shareholders' Meeting
Date of events 2022/05/30 To which item it meets paragraph 18
Statement 
1.Date of the shareholders' meeting:2022/05/30
2.Important resolutions  I.Profit distribution/deficit compensation:
 Acknowledgment of the 2021 deficit compensation
3.Important resolutions II.Amendments of the company charter:
 Approved the amendments of the company charter
4.Important resolutions III.Business report and financial statements:
 Acknowledgment of the 2021 business report and financial statements
5.Important resolutions IV.Election for directors and supervisors:
 The list of persons elected as belows:
 Newly-appointed directors:
 (1) James Chang
 (2) Hui-Chuan, Chang(Representative of National Development Fund)
 (3) Shih Chia Lin(Representative of National Development Fund)
 (4) Frank Chen(Representative of Chang Chun Investment)
 (5) Tien-Chieh, Lee(Representative of Huei Hong Investment)
 (6) Tamon Tseng(Representative of Yi Tai Investment)
 Newly-appointed independent directors:
 (7) Chin-Ting, Chiu
 (8) Howard S. Lee
 (9) Gwo-Fong, Lin
6.Important resolutions V.Other matters:
 (1) Approved the amendment to the Operational procedures for Acquisition and
     Disposal of Assets.
 (2) Approved the lifting of non-competition restrictions for directors.
7.Any other matters that need to be specified:None

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

TaiMed Biologics Inc. published this content on 30 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 May 2022 14:48:13 UTC.